Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-88106
Key Product Details
Sample Type & Volume Required Per Well
Cell culture supernatant, serum, plasma (EDTA, citrate, heparin), buffered solution (50 uL)
Sensitivity
0.27 ng/mL
Assay Range
0.31 - 20.0 ng/mL
Product Specifications
Assay Type
Sandwich ELISA
Kit Type
ELISA Kit (Colorimetric)
Reactivity
Human
Specificity
This assay detects soluble IL-2R in human serum, plasma, buffered solution, or cell culture medium. It will exclusively recognize both natural and recombinant human IL-2R.
Description
The human sIL-2R ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human sIL-2R
Precision
Intra-Assay Precision (Precision within an assay) CV% < 7.2%
Inter-Assay Precision (Precision between assays) CV% < 9.8%
Recovery for Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
Recovery
75%
Scientific Data Images for Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
ELISA: Human CD25/IL-2R alpha ELISA Kit (Colorimetric) [NBP1-88106]
ELISA: CD25/IL-2 R alpha ELISA Kit [NBP1-88106] - Standard curveKit Contents for Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
- Aluminium pouch(es) with a Microwell Plate coated with monoclonal antibody to human GRO alpha (CXCL1)
Preparation and Storage
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Storage of components varies. See protocol for specific instructions.
Background: CD25/IL-2R alpha
Long Name
Interleukin 2 Receptor alpha
Alternate Names
CD25, IL-2 R alpha, IL-2Ra, IL2R alpha, IL2RA
Gene Symbol
IL2RA
Additional CD25/IL-2R alpha Products
Product Documents for Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
Product Specific Notices for Human CD25/IL-2R alpha ELISA Kit (Colorimetric)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. ELISA Kits are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...
Loading...